NewsAbortion, Politics - U.S. Tue Apr 23, 2019 - 4:11 pm EST
Mifepristone - Latest News
NewsAbortion, Politics - U.S. Thu Apr 18, 2019 - 4:51 pm EST
Oklahoma legislature sends abortion pill reversal law to pro-life governor’s desk
By Calvin Freiburger
NewsAbortion, Politics - U.S. Tue Mar 12, 2019 - 5:50 pm EST
FDA warns websites selling abortion pills without prescriptions: you’re breaking the law
By Calvin Freiburger
NewsAbortion, Politics - U.S. Thu Aug 30, 2018 - 12:51 pm EST
California Assembly votes to mandate colleges to dispense abortion pills
By Calvin Freiburger
NewsAbortion Tue Aug 28, 2018 - 3:40 pm EST
Home abortion now legal in England despite disastrous effects
By Society for the Protection of Unborn Children
NewsAbortion Wed Aug 8, 2018 - 12:12 pm EST
Do abortion-supporters care about the danger and destruction of the abortion pill?
By Society for the Protection of Unborn Children
NewsAbortion, Politics - U.S. Thu Aug 2, 2018 - 3:54 pm EST
Pro-abortion org. slams abortion reversal as ‘human experimentation’ but backs fetal tissue research
By Calvin Freiburger
NewsAbortion Fri Jul 20, 2018 - 1:12 pm EST
Abortion pill complications skyrocket in Ohio
By Cheryl Sullenger
NewsAbortion, Politics - U.S. Thu Jun 14, 2018 - 3:14 pm EST
Abortion queen Cecile Richards: Pills that kill preborn babies are ‘safer than Tylenol’
By Calvin Freiburger
OpinionAbortion Thu Dec 14, 2017 - 2:14 pm EST
Commenting Guidelines
LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.
LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.
Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).
LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.
Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.